BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
1-Year Return
36.47%
This Quarter Return
+11.77%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$894M
AUM Growth
-$76.8M
(-7.9%)
Cap. Flow
-$62M
Cap. Flow
% of AUM
-6.93%
Top 10 Holdings %
Top 10 Hldgs %
76.13%
Holding
32
New
–
Increased
2
Reduced
6
Closed
1
Top Buys
| 1 |
Tango Therapeutics
TNGX
|
+$10.9M |
| 2 |
Savara
SVRA
|
+$9.87M |
Top Sells
| 1 |
Crinetics Pharmaceuticals
CRNX
|
+$30.6M |
| 2 |
CBAY
Cymabay Therapeutics
CBAY
|
+$23.6M |
| 3 |
Dynavax Technologies
DVAX
|
+$22.2M |
| 4 |
THRD
Third Harmonic Bio
THRD
|
+$3.08M |
| 5 |
Pharvaris
PHVS
|
+$1.76M |
Sector Composition
| 1 | Healthcare | 98.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Xilio Therapeutics
XLO
$38.2M
| $5.92M | 0.66% |
2,805,413
| – | – |
|
|
TSVT
27
DELISTED
2seventy bio
TSVT
| $5.52M | 0.62% |
1,408,901
| – | – |
|
28
Invivyd
IVVD
$299M
| $3.29M | 0.37% |
1,937,207
| – | – |
|
29
C4 Therapeutics
CCCC
$189M
| $3.05M | 0.34% |
1,642,210
| – | – |
|
30
NewAmsterdam Pharma Company N.V. Warrant
NAMSW
$62.3M
| $190K | 0.02% |
100,000
| – | – |
|
|
TVRD
31
Tvardi Therapeutics, Inc. Common Stock
TVRD
$318M
| $39.7K | ﹤0.01% |
657
-25,312
| -97% | -$1.53M |
|
|
THRD
32
DELISTED
Third Harmonic Bio
THRD
| – | – |
-640,631
| Closed | -$3.08M |
|